No doubt, but because he is Twiggy he can invest in Carina where I can't.
Having said that, here are the facts as I see them:
1AD owns the technology to produce a billion different antigen-receptors that Carina might need. This is a much better bet than having one shot on goal - that of making the solid tumor cells look like blood cancer cells that express a particular antigen (CD-19) and hoping your (CD-19) CAR-T works better than other (CD-19) CAR-T 's already out there.
And Carina own their technology.
So there is no licensing of technologies from US that no-one in the US wanted.
At a Market Cap of $25M you are getting a lot more bang for your buck here, I would think.
Also I don't have to read the stomach churning sycophantic adulation for entrepreneurs on the other company threads.
Just my opinions, possibly wrong.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.142M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 833997 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 1337995 | 2 |
View Market Depth
| Last trade - 09.42am 24/06/2025 (20 minute delay) ? |
| 1AD (ASX) Chart |
Day chart unavailable